Chloroquine ‘Approval’ For COVID-19 And The US FDA’s New Reality
Executive Summary
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
You may also be interested in...
FDA's Emergency Use Authorization for Malaria Drugs Could Hinder Trials of Other COVID-19 Treatments
Questions linger about the role the White House played in pushing the EUA, which comes with large product donations from Bayer and Sandoz that are expected to alleviate supply chain pressures for the drugs.
US FDA Commissioner Hahn’s Star Turn: Baptism By Fire Turns Perilous
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
Off-Label Promoter In Chief: President Trump Pushes COVID-19 Therapy
If the President says over and over again that a drug is approved, does that make it so?